Results 181 to 190 of about 677,032 (302)
Olfactory tuft cells communicate with other mucosal cells in maintaining olfactory epithelial immunity and sensory function. Disruption of tuft cell signalling pathways causes a skewed immune response, leading to heightened inflammation and increased activation of the quiescent stem cells, which are further exacerbated by viral infection.
Sai‐Sai Zhang +7 more
wiley +1 more source
ABSTRACT COVID‐19 intensified ethical tensions between clinicians' duty to care and self‐protection amid PPE shortages. We explored frontline healthcare professionals' perspectives in Maputo, Mozambique. Semi‐structured interviews with healthcare professionals at four hospitals (April–June 2022) were recorded in Portuguese, transcribed, and ...
Ângela Alface +5 more
wiley +1 more source
Assessment of Humoral Immunogenicity of ChAdOx1 H5 HA Influenza Vaccine for Dairy Cattle. [PDF]
Dema B +13 more
europepmc +1 more source
Inborn errors of immunity in children with neuroinflammation
Abstract Inborn errors of immunity (IEIs), an expanding group of monogenic disorders with diverse clinical manifestations, are increasingly recognized to include neuroinflammatory disease. Examples of diseases included under this umbrella are Aicardi–Goutières syndrome, deficiency of adenosine deaminase 2, familial haemophagocytic lymphohistiocytosis ...
Eppie M Yiu +5 more
wiley +1 more source
Age-dependent immune landscapes affect influenza vaccine effectiveness and guide precision strategies. [PDF]
Liu J, Zhang Z, Zhang J, Nian X.
europepmc +1 more source
Abstract Aims Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is more severe in people with diabetes mellitus due to immune dysfunction, exacerbated inflammation and increased risk of co‐morbidities and mortality.
Taís Mendes Camargo +4 more
wiley +1 more source
Statins, Influenza Vaccination and Influenza [PDF]
openaire +2 more sources
T‐Cell Response After SARS‐CoV‐2 Vaccination in Patients With Hematological Malignancy
ABSTRACT Patients with hematologic malignancies (HM) often mount poor humoral responses to SARS‐CoV‐2 vaccination due to their immunocompromised status. Protection against severe COVID‐19 is strongly related to cellular immunity, yet vaccine‐induced T‐cell responses remain incompletely characterized.
L. S. Boerenkamp +7 more
wiley +1 more source
Carvacrol nanoemulsion as a novel approach to augment H9N2 influenza vaccine efficacy. [PDF]
Alanazi H +13 more
europepmc +1 more source
Measles Infoveillance and Infodemiology in Italy: A Study From 2013 to 2025
Acta Paediatrica, EarlyView.
Omar Enzo Santangelo +5 more
wiley +1 more source

